These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29976785)

  • 21. Adherence to Growth Hormone Treatment in Children During the COVID-19 Pandemic.
    Eren E; Çetinkaya S; Denkboy Öngen Y; Tercan U; Darcan Ş; Turan H; Aydın M; Yavuzyılmaz F; Kilci F; Selver Eklioğlu B; Hatipoğlu N; Yüksek Acinikli K; Orbak Z; Çamtosun E; Savaş Erdeve Ş; Arslan E; Ercan O; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2024 Sep; 16(3):256-263. PubMed ID: 38488049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Real-World Treatment Patterns and Outcomes of Growth Hormone Treatment Among Children in Israel Over the Past Decade (2004-2015).
    Ben-Ari T; Chodick G; Shalev V; Goldstein D; Gomez R; Landau Z
    Front Pediatr; 2021; 9():711979. PubMed ID: 34490167
    [No Abstract]   [Full Text] [Related]  

  • 23. Adherence to somatotropin treatment administered with an electronic device.
    Arrabal Vela MA; García Gijón CP; Pascual Martin M; Benet Giménez I; Áreas Del Águila V; Muñoz-Rodríguez JR; Palomo Atance E
    Endocrinol Diabetes Nutr (Engl Ed); 2018; 65(6):314-318. PubMed ID: 29680781
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth hormone treatment adherence in prepubertal and pubertal children with different growth disorders.
    Hartmann K; Ittner J; Müller-Rossberg E; Schönau E; Stephan R; Ullrich KP; Hoppe B; Ramseger R; Brämswig J
    Horm Res Paediatr; 2013; 80(1):1-5. PubMed ID: 23860437
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term safety and efficacy of Omnitrope®, a somatropin biosimilar, in children requiring growth hormone treatment: Italian interim analysis of the PATRO Children study.
    Iughetti L; Tornese G; Street ME; Napoli F; Giavoli C; Antoniazzi F; Stagi S; Luongo C; Azzolini S; Ragusa L; Bona G; Zecchino C; Aversa T; Persani L; Guazzarotti L; Zecchi E; Pietropoli A; Zucchini S
    Ital J Pediatr; 2016 Nov; 42(1):93. PubMed ID: 27809913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improvement of treatment adherence with growth hormone by easypod™ device: experience of an Italian centre.
    Maggio MC; Vergara B; Porcelli P; Corsello G
    Ital J Pediatr; 2018 Sep; 44(1):113. PubMed ID: 30261918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Positive Impact of Targeted Educational Intervention in Children With Low Adherence to Growth Hormone Treatment Identified by Use of the Easypod™ Electronic Auto-injector Device.
    Assefi AR; Roca F; Rubstein A; Chareca C
    Front Med Technol; 2021; 3():609878. PubMed ID: 35047902
    [No Abstract]   [Full Text] [Related]  

  • 28. The adult growth hormone multicentric retrospective observational study: a 24-month Italian experience of adherence monitoring via Easypod™ of recombinant growth hormone treatment in adult GH deficiency.
    Mancini A; Vergani E; Bruno C; Giavoli C; Spaziani M; Isidori AM; Arosio M; Pontecorvi A
    Front Endocrinol (Lausanne); 2023; 14():1298775. PubMed ID: 38027149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of radiation-induced growth hormone deficiency with growth hormone-releasing hormone.
    Ogilvy-Stuart AL; Stirling HF; Kelnar CJ; Savage MO; Dunger DB; Buckler JM; Shalet SM
    Clin Endocrinol (Oxf); 1997 May; 46(5):571-8. PubMed ID: 9231053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improving adherence to GH therapy with an electronic device: first experience with easypod.
    Kirk J
    Pediatr Endocrinol Rev; 2009 Jun; 6 Suppl 4():549-52. PubMed ID: 19550392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric growth hormone therapy in Greece: analysis of the Hellenic cohort of the GeNeSIS study.
    Kosteria I; Aloumanis K; Kanaka-Gantenbein C; Vlachopapadopoulou E; Michalacos S; Stamoyannou L; Drossinos E; Chrousos G;
    Hormones (Athens); 2019 Dec; 18(4):423-434. PubMed ID: 31696446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
    Ross JL; Lee PA; Gut R; Germak J
    Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ease of use and acceptability of a new pen device for the administration of growth hormone therapy in pediatric patients: an open-label, uncontrolled usability test.
    Fuchs GS; Mikkelsen S; Knudsen TK; Kappelgaard AM
    Clin Ther; 2009 Dec; 31(12):2906-14. PubMed ID: 20110030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment adherence with the easypod™ growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parents.
    Bozzola M; Colle M; Halldin-Stenlid M; Larroque S; Zignani M;
    BMC Endocr Disord; 2011 Feb; 11():4. PubMed ID: 21294891
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Easypod: a new electronic injection device for growth hormone.
    Dahlgren J
    Expert Rev Med Devices; 2008 May; 5(3):297-304. PubMed ID: 18452378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Real-life GH dosing patterns in children with GHD, TS or born SGA: a report from the NordiNet® International Outcome Study.
    Blankenstein O; Snajderova M; Blair J; Pournara E; Pedersen BT; Petit IO
    Eur J Endocrinol; 2017 Aug; 177(2):145-155. PubMed ID: 28522645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone treatment does not to lead to insulin resistance nor excessive rise in IGF-1 levels, while improving height in patients small for gestational age A long-term observational study.
    López-Siguero JP; Martínez-Aedo MJ; Bermúdez de la Vega JA; Bosch-Muñoz J; Lechuga-Sancho AM; Villalobos T;
    Clin Endocrinol (Oxf); 2022 Apr; 96(4):558-568. PubMed ID: 34882803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness and cost-utility analysis of somatrogon once-weekly injections vs. daily growth hormone injection for treating paediatric growth hormone deficiency in Ireland.
    Rivolo S; Loftus J; Peter B; Fahey M; Kongnakorn T
    J Med Econ; 2023; 26(1):963-972. PubMed ID: 37527156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adherence to growth hormone therapy in children and its potential barriers.
    Mohseni S; Heydari Z; Qorbani M; Radfar M
    J Pediatr Endocrinol Metab; 2018 Jan; 31(1):13-20. PubMed ID: 29216008
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth Hormone Treatment for Short Stature in the USA, Germany and France: 15 Years of Surveillance in the Genetics and Neuroendocrinology of Short-Stature International Study (GeNeSIS).
    Pfäffle R; Land C; Schönau E; Holterhus PM; Ross JL; Piras de Oliveira C; Child CJ; Benabbad I; Jia N; Jung H; Blum WF
    Horm Res Paediatr; 2018; 90(3):169-180. PubMed ID: 30199857
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.